FGF2 and breast carcinoma: The derivative peptide P7, obtained by screening using the phage surface display technology and specifically binding to FGF2, can also block the activation of the ERK and P38 signaling pathways, effectively inhibiting the proliferation of breast cancer cells induced by FGF2 [62].